Understanding how low-nicotine cigarettes affect beliefs and smoking behavior
Official title: Differentiating harms from combustion vs. addiction: Effects of low nicotine cigarette education on beliefs and behaviors
Funded at Rutgers Biomedical and Health Sciences · NIH-11449008 · Data updated 2026-11-12
This grant tests how people understand nicotine versus burning tobacco and whether education about low-nicotine cigarettes changes their beliefs and smoking choices.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers Biomedical and Health Sciences NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project start | September 15, 2026 |
| Project end | May 31, 2031 |
| Funding year | 2026 |
| Award (this year) | $722,948 |
| NIH project number | 1R01DA064651-01A1 |
| Project ID | NIH-11449008 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults 21 years and older who currently smoke cigarettes.
✕Less likely to help
Individuals not exposed to the messaging or not currently smoking may not experience direct benefits.
What this research studies
The project looks at how messaging about low-nicotine cigarettes influences what adults think about harm and addiction, and whether these beliefs lead to changes in their smoking behavior. Researchers will use randomized methods to present information and measure changes in knowledge, attitudes, and potential quitting or switching behaviors. The study builds on prior work to clarify how misperceptions about nicotine and combustion may affect health decisions in people who smoke. Results could guide public health communications and policy to reduce tobacco-related disease.
Why it matters
Potential benefit: If successful, the findings could help design clearer messages that promote quitting and reduce risky switching to perceived “safer” tobacco products.
How similar studies have gone: Previous work has shown messaging can shift beliefs, but optimal education strategies for low-nicotine products require further study.
Where this research is happening
-
Rutgers Biomedical and Health Sciences
Newark, United States Active
Researchers
- Principal investigator: Villanti, Andrea — Rutgers Biomedical and Health Sciences
- Study coordinator: Villanti, Andrea
Related research
Other NIH-funded projects on the same topics.
-
Reducing Addiction Risk in High Schools Through Better Prevention Infrastructure
Aims to build a sustainable, school-based system to prevent opioid and other drug use among high school students, especially those at higher risk.
-
HEAL Data Platform to share addiction-related data across programs
A platform project to make HEAL data from many programs easier to find and use, helping researchers and clinicians access information about addiction in children and youth.
-
Cognitively-enhanced tDCS to reduce cocaine craving
A study to test whether real brain stimulation together with learning strategies can lessen craving in people with cocaine use disorder.
-
Yale center researching how tobacco products affect use and addiction in people
A Yale research center is studying how nicotine, flavor additives, and other ingredients in tobacco products influence people’s likelihood of starting and becoming addicted.
-
Atherosclerosis in cocaine addiction: imaging risk with PET/MR
This project uses PET/MR imaging to look for early artery disease in people with cocaine use disorder to help prevent strokes or other brain injuries.
-
Integrating long-acting PrEP into street medicine for people who use drugs
This project tests whether a long-acting HIV prevention shot (lenacapavir) can be feasibly and acceptably offered by street-based health teams to people who use drugs.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.